Literature DB >> 12737630

Role of activator protein-1 in the down-regulation of the human CYP2J2 gene in hypoxia.

Nicole Y Marden1, Eva Fiala-Beer, Shi-Hua Xiang, Michael Murray.   

Abstract

The cytochrome P450 (CYP) 2J2 arachidonic acid epoxygenase gene was down-regulated at a pre-translational level in human hepatoma-derived HepG2 cells incubated in a hypoxic environment; under these conditions, the expression of c-Jun and c-Fos mRNA and protein was increased. The 5'-upstream region of the CYP2J2 gene was isolated by amplification of a 2341 bp fragment and putative regulatory elements that resembled activator protein-1 (AP-1)-like sequences were identified. From transient transfection analysis, c-Jun was found to strongly activate a CYP2J2 -luciferase reporter construct, but co-transfection with plasmids encoding c-Fos or c-Fos-related antigens, Fra-1 and -2, abrogated reporter activity. Using a series of deletion-reporter constructs, a c-Jun-responsive module was identified between bp -152 and -50 in CYP2J2 : this region contained an AP-1-like element between bp -56 and -63. The capacity of this element to interact directly with c-Jun, but not c-Fos, was confirmed by electromobility-shift assay analysis. Mutagenesis of the -56/-63 element abolished most, but not all, of the activation of CYP2J2 by c-Jun, thus implicating an additional site within the c-Jun-responsive region. The present results establish an important role for c-Jun in the control of CYP2J2 expression in liver cells. Activation of c-Fos expression by hypoxia promotes the formation of c-Jun/c-Fos heterodimers, which decrease the binding of c-Jun to the CYP2J2 upstream region, leading to gene down-regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12737630      PMCID: PMC1223548          DOI: 10.1042/BJ20021903

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  45 in total

1.  Hypoxia-induced bFGF gene expression is mediated through the JNK signal transduction pathway.

Authors:  Y J Le; P M Corry
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

Authors:  K Node; Y Huo; X Ruan; B Yang; M Spiecker; K Ley; D C Zeldin; J K Liao
Journal:  Science       Date:  1999-08-20       Impact factor: 47.728

4.  c-Jun is a JNK-independent coactivator of the PU.1 transcription factor.

Authors:  G Behre; A J Whitmarsh; M P Coghlan; T Hoang; C L Carpenter; D E Zhang; R J Davis; D G Tenen
Journal:  J Biol Chem       Date:  1999-02-19       Impact factor: 5.157

5.  CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance.

Authors:  D C Zeldin; J Foley; J Ma; J E Boyle; J M Pascual; C R Moomaw; K B Tomer; C Steenbergen; S Wu
Journal:  Mol Pharmacol       Date:  1996-11       Impact factor: 4.436

6.  Differential effects of flavonoid compounds on tumor promoter-induced activation of the human CYP1A2 enhancer.

Authors:  H Shih; G V Pickwell; L C Quattrochi
Journal:  Arch Biochem Biophys       Date:  2000-01-01       Impact factor: 4.013

7.  Differential activation of some transcription factors during rat liver ischemia, reperfusion, and heat shock.

Authors:  L Tacchini; L Radice; A Bernelli-Zazzera
Journal:  J Cell Physiol       Date:  1999-08       Impact factor: 6.384

8.  c-Jun transactivates the promoter of the human p21(WAF1/Cip1) gene by acting as a superactivator of the ubiquitous transcription factor Sp1.

Authors:  D Kardassis; P Papakosta; K Pardali; A Moustakas
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

9.  Coordinate up-regulation of CYP1A1 and heme oxygenase-1 (HO-1) expression and modulation of delta-aminolevulinic acid synthase and tryptophan pyrrolase activities in pyridine-treated rats.

Authors:  M M Iba; J Alam; C Touchard; P E Thomas; A Ghosal; J Fung
Journal:  Biochem Pharmacol       Date:  1999-08-15       Impact factor: 5.858

10.  c-JUN gene induction and AP-1 activity is regulated by a JNK-dependent pathway in hypoxic HepG2 cells.

Authors:  E Minet; G Michel; D Mottet; J P Piret; A Barbieux; M Raes; C Michiels
Journal:  Exp Cell Res       Date:  2001-04-15       Impact factor: 3.905

View more
  10 in total

Review 1.  Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s.

Authors:  Viola Tamási; Katalin Monostory; Russell A Prough; András Falus
Journal:  Cell Mol Life Sci       Date:  2010-12-24       Impact factor: 9.261

Review 2.  Lipid analogues as potential drugs for the regulation of mitochondrial cell death.

Authors:  Michael Murray; Herryawan Ryadi Eziwar Dyari; Sarah E Allison; Tristan Rawling
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

3.  Activator protein-1 regulation of murine aldehyde dehydrogenase 1a1.

Authors:  N L Makia; I Amunom; K C Falkner; D J Conklin; S Surapureddi; J A Goldstein; R A Prough
Journal:  Mol Pharmacol       Date:  2012-06-26       Impact factor: 4.436

4.  Characterization of a c-Jun-responsive module in the 5'-flank of the human CYP2J2 gene that regulates transactivation.

Authors:  Nicole Y Marden; Michael Murray
Journal:  Biochem J       Date:  2005-11-01       Impact factor: 3.857

5.  Impaired transactivation of the human CYP2J2 arachidonic acid epoxygenase gene in HepG2 cells subjected to nitrative stress.

Authors:  Pei H Cui; Andy C Lee; Fanfan Zhou; Michael Murray
Journal:  Br J Pharmacol       Date:  2010-02-24       Impact factor: 8.739

6.  Gene expression in rats with Barrett's esophagus and esophageal adenocarcinoma induced by gastroduodenoesophageal reflux.

Authors:  Peng Cheng; Jun Gong; Tao Wang; Jie Chen; Gui-Sheng Liu; Ru Zhang
Journal:  World J Gastroenterol       Date:  2005-09-07       Impact factor: 5.742

Review 7.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

8.  Regulation of molecular pathways in ischemia-reperfusion injury after liver transplantation.

Authors:  Ricardo C Gehrau; Valeria R Mas; Catherine I Dumur; Danielle E Ladie; Jihee L Suh; Samuel Luebbert; Daniel G Maluf
Journal:  Transplantation       Date:  2013-11-27       Impact factor: 4.939

9.  The role of cytochrome P450 epoxygenases in retinal angiogenesis.

Authors:  Megan E Capozzi; Gary W McCollum; John S Penn
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-06-10       Impact factor: 4.799

10.  Hepatic Cyp1a2 Expression Reduction during Inflammation Elicited in a Rat Model of Intermittent Hypoxia.

Authors:  Li-Xia Shi; Xing Wang; Qi Wu; Xin Sun; Zhen Wan; Li Li; Kuan Li; Xue Li; Yu Li; Qiu-Yang Zhang; Jun-Ping Wu; Huai-Yong Chen
Journal:  Chin Med J (Engl)       Date:  2017-11-05       Impact factor: 2.628

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.